Skip to main content
ZR2 BIOENERGY LIMITED logo

ZR2 BIOENERGY LIMITED — Investor Relations & Filings

Ticker · 506640 ISIN · INE218N01021 BSE.NS Electricity, gas, steam and air conditioning supply
Open in API
Filings indexed 442 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS 506640

About ZR2 BIOENERGY LIMITED

https://gujchemdistillers.in/

ZR2 Bioenergy Limited specializes in the development and operation of renewable energy projects, with a primary focus on bioenergy production. The company utilizes advanced technologies to convert organic waste and biomass into sustainable energy sources, including compressed biogas (CBG) and high-quality organic fertilizers. By integrating waste management with energy generation, the firm addresses environmental challenges while providing clean fuel alternatives for industrial and commercial applications. Its core activities encompass the design, construction, and management of bio-refineries, aiming to optimize resource recovery and promote a circular economy. The company serves diverse sectors seeking to reduce carbon footprints and transition toward carbon-neutral energy solutions through efficient biomass processing and waste-to-energy conversion.

Recent filings

Filing Released Lang Actions
ZR2 Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve In compliance with Regulation ....
Regulatory Filings Classification · 82% confidence The document is a compliance announcement under Regulation 29 of SEBI’s LODR Regulations notifying BSE of a forthcoming Board meeting to consider and approve audited financial results. It does not contain actual financial data or the results themselves, nor is it a certification, dividend notice, proxy material, or management change. It is a general regulatory announcement. Thus it falls under the fallback category Regulatory Filings (RNS).
2026-05-26 English
MONITORING AGENCY REPORT FOR THE QUARTER ENDED 31ST MARCH, 2026
Regulatory Filings Classification · 95% confidence The document is a SEBI‐mandated Monitoring Agency Report filed by ZR2 Bioenergy with the stock exchange under Listing Regulations and ICDR Regulations. It is a compliance submission detailing utilization of proceeds from a preferential issue, including tables and qualifications by Crisil Ratings. It is not a full interim financial report (IR), nor an earnings release (ER) nor a capital-raising announcement (CAP). It is a regulatory compliance filing that does not fit any other specific category, and therefore falls under Regulatory Filings (RNS).
2026-05-15 English
Dear Sir/Madam, We write to inform you that in accordance with the Company's Code of Conduct for Insider Trading ('Code') read with applicable provisions of SEBI (Prohibition of Insider ....
Regulatory Filings Classification · 95% confidence The document is a notification from ZR2 Bioenergy Limited to BSE Limited about the closure of the trading window for insiders in compliance with SEBI regulations. It mentions the upcoming approval and dissemination of audited financial results for the quarter and financial year ended March 31, 2026, but does not contain any financial data or the results themselves. The document is short (1812 characters) and serves as an announcement related to insider trading restrictions ahead of financial results publication. Therefore, it is not a financial report or earnings release but a regulatory announcement related to trading restrictions.
2026-04-19 English
Dear Sir/Madam, Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find enclosed herewith a confirmation ....
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations 2018, confirming dematerialisation activities for the quarter ended March 31, 2026. It is a compliance certificate from the Registrar and Transfer Agent to the stock exchange. The document is short (3016 characters) and primarily serves as a regulatory confirmation rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is an officer certification related to regulatory compliance. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2026-04-13 English
This is in furtherance of the intimation given by the Company on May 10, 2024, wherein we had informed you that the Company had allotted 2,59,22,000 convertible warrants of the Company ....
Share Issue/Capital Change Classification · 95% confidence The document is an official communication addressed to the stock exchange (BSE Limited) regarding the non-exercise of conversion options on convertible warrants allotted on a preferential basis. It details the forfeiture of the initial subscription amount due to the warrants not being converted within the stipulated 18 months. The document references compliance with SEBI regulations and provides a list of warrant holders and forfeited amounts. It is a regulatory disclosure about capital structure changes related to warrants and forfeiture, not a full financial report or earnings release. The document length is 3456 characters, which is relatively short and focused on a specific capital event. Therefore, it fits best under the category of Share Issue/Capital Change (SHA) as it concerns forfeiture related to convertible warrants and capital changes.
2026-02-19 English
Allotment of 1,23,50,000 Additional Equity Shares (on account of conversion of Compulsorily Convertible Debentures ('CCDs') into equity shares.
Share Issue/Capital Change Classification · 100% confidence The document is an official communication addressed to the stock exchange (BSE Limited) regarding the allotment of additional equity shares due to the conversion of Compulsorily Convertible Debentures (CCDs) into equity shares. It references SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and provides detailed information about the share allotment, pricing, and post-issue shareholding. The content is focused on a capital structure change and share issuance event, not a financial report, earnings release, or management discussion. The document length is about 4917 characters, which is sufficient for a detailed announcement. Therefore, this document fits the category of a Share Issue/Capital Change announcement.
2026-02-19 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.